Radiopharmaceuticals for Therapeutic Market, by Types (Radium-223,Lutetium-177,Iodine-131,Other), by Applications (Thyroid,Bone Metastasis,Lymphoma,Other) and Region: Global Opportunity Analysis and Industry Forecast, 2024-2034

The report provides a detailed analysis of current market trends, industry drivers & restraints, and other growth prospects. Furthermore, information on the basis of regional study of the market is provided in the report. The market is studied across regions such as Asia-Pacific, North America, Europe, and LAMEA. Each region is analyzed at the country level.

The report covers quantitative analysis to recognize the predominant opportunities with strategic assessment of the Radiopharmaceuticals for therapeutic market. Along with this, the report provides information regarding the major market players and their development strategies to understand the competitive scenario of the market.

Research Methodology

The estimation and validation of the Radiopharmaceuticals for therapeutic market size and various other dependent submarkets are provided using the top-down and bottom-up approaches.

Bottom-up Approach: The bottom-up approach is used to reach the overall market size of the Radiopharmaceuticals for therapeutic market by estimating the revenue generation and value of the market, through secondary and primary research.

Top-down Approach: The market size obtained from the bottom-up approach is applied in the top-down approach to estimate the size of other segments presented in the table of content through percentage splits from secondary and primary research. This overall market size is used in the top-down approach to estimate regional consumption.

Data Triangulation: To triangulate the data derived from the market size estimation process explained above, the total market is split into other segments.

With this methodology, AMR triangulates the market size estimation and ensures that our analysis is aligned with the industry situation.

Key Market Benefits

• This report provides overall information on current trends, key determinants, and future estimation of the Radiopharmaceuticals for therapeutic market.

• The market size and estimations are based on a detailed analysis of key developments in the Radiopharmaceuticals for therapeutic market.

• This report provides a thorough analysis of top market players.

• The report covers development strategies adopted by the key market players to understand the competitive scenario of the market.

Key Companies identified in the report are Bayer Novartis China Isotope and Radiation Dongcheng Q BioMed Curium Pharmaceuticals Jubilant DraxImage Lantheus Spectrum Pharmaceuticals Progenics Pharmaceuticals International Isotopes

Additional Customization

To cater to company’s/client’s market data requirements, AMR offers customization option to all reports. Some of the options, but are not limited to, are:

• Additional company profiles

• Regional/country additions

• Criss-cross market segmentation

• Qualitative information (SWOT analysis, supply chain analysis, and pricing analysis)

  Radiopharmaceuticals for Therapeutic Market, by Types Report Highlights

Aspects	Details
By Types	Radium-223 Lutetium-177 Iodine-131 Other
By Applications	Thyroid Bone Metastasis Lymphoma Other
By Region	North America  (UNITED STATES, CANADA, MEXICO) Europe  (FRANCE, GERMANY, ITALY, SPAIN, UNITED KINGDOM, Rest of Europe) Asia-Pacific  (CHINA, JAPAN, INDIA, SOUTH KOREA, AUSTRALIA, Rest of Asia Pacific) LAMEA  (Brazil, South Africa,, Saudi Arabia, Rest of LAMEA)
Key Market Players	Lantheus, Northstar Medical Radioisotopes, Fusion Pharmaceuticals Inc., Jubilant Pharmova Limited, Actinium Pharmaceuticals, Eli Lilly And Company, PRECIRIX, Novartis AG, Cardinal Health, Curium Pharma

^*Terms and Conditions Apply